Today, Genetrump is proud to announce that we have been awarded a non-repayable grant of MOP 1,000,000 from the Macao Science and Technology Development Fund (FDCT).
The FDCT is the primary public institution of the Macao SAR government dedicated to promoting scientific and technological innovation and its commercial translation. Securing an FDCT grant, which involves a rigorous evaluation of a project's scientific merit and commercial viability, represents the highest level of official endorsement for our technology and its industrial potential.
This crucial funding will be specifically allocated to the "Development of an Industrial-Scale Manufacturing Process for the Active Polysaccharide from Eucommia ulmoides." This marks a pivotal transition for our core technology, moving from the laboratory research phase to the preparatory stage for large-scale, standardized industrial production. It is a critical step in transforming our scientific discovery into a market-ready product, addressing key challenges in mass production, cost-efficiency, and quality control.
Receiving this governmental financial support is not only the ultimate validation of our team's past efforts but also lays a solid foundation for subsequent product development and market entry. It signals Genetrump's official entry onto a new fast track of integrated industrial-scale R&D.
Source: Genetrump News